Both real and 'sham' acupuncture help ease side effects of widely used breast cancer drug

December 23, 2013

BALTIMORE - December 23, 2013. Breast cancer patients experience fewer side effects while being treated with a widely used drug called an aromatase inhibitor when they get acupuncture - either the real treatment or a "sham" procedure, according to a new study led by researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center. Their findings are published online in Cancer, a peer-reviewed journal of the American Cancer Society.

"We found that patients with early stage, hormone receptor-positive breast cancer taking an aromatase inhibitor showed significant improvement in some symptoms, especially hot flashes, after eight weekly treatments with real acupuncture or sham acupuncture," says lead author Ting Bao, M.D., D.A.B.M.A, M.S., assistant professor of medicine at the University of Maryland School of Medicine and research scientist at the University of Maryland Greenebaum Cancer Center.

"There was no statistically significant difference between the two interventions," Dr. Bao says. She notes that the study sample of 47 women - 23 who received real acupuncture and 24 who had the sham procedure - may not have been large enough to detect a distinction. In addition, sham acupuncture, which is performed using non-penetrating, retractable needles at non-acupuncture points in the body, may have some unexplained physiological effects. "We are not convinced that sham acupuncture is totally inert," she says.

"Importantly, neither type of acupuncture produced any significant side effects, which is good news for patients," Dr. Bao says.

Up to 60 percent of postmenopausal women with breast cancer who take an aromatase inhibitor, which inhibits an enzyme involved in producing estrogen, experience joint and muscle pain and other side effects, such as hot flashes, anxiety and depression. The study findings may lend support to the use of acupuncture to treat these symptoms.

"If we really want to find something that will help patients, acupuncture is a reasonable alternative to drug therapy, which can produce its own set of side effects," Dr. Bao says. For example, antidepressants used to treat hot flashes can cause side effects such as nausea, constipation, dry mouth and drowsiness.

According to Dr. Bao, the research team did not set out to look at racial differences, but in analyzing the data, found that African-American patients benefited more than non-African-Americans from real acupuncture, compared to sham acupuncture, in reducing the severity and frequency of hot flashes. Researchers plan additional studies to investigate this finding.

The patients enrolled in the study were treated at the University of Maryland Greenebaum Cancer Center and the Johns Hopkins Kimmel Cancer Center. Vered Stearns, M.D., professor of oncology at the Johns Hopkins University School of Medicine and co-director of the breast cancer program at the Kimmel Cancer Center, is the study's senior author.

The research was supported by grants from the American Society of Clinical Oncology, Susan G. Komen for the Cure, the Breast Cancer Research Foundation, the Maryland affiliate of Susan G. Komen and the National Cancer Institute (K12 CA126849, R21 CA173263).

E. Albert Reece, M.D., Ph.D., M.B.A., vice president for medical affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the University of Maryland School of Medicine, says, "Aromatase inhibitors are a very important advance in treating postmenopausal women with estrogen receptor-positive breast cancer, but side effects may cause some patients to stop treatment. This study led by Dr. Bao, an oncologist and medical acupuncturist, offers some intriguing evidence that acupuncture - even sham acupuncture - may be helpful in alleviating some side effects. These findings warrant further investigation."

In February 2013, Dr. Bao and her colleagues reported similar findings in the journal Breast Cancer Research and Treatment in regard to joint and muscle pain associated with treatment with aromatase inhibitors. They found that acupuncture and sham acupuncture improved breast cancer patients' symptoms but saw no statistical difference between the two interventions.
-end-
About the University of Maryland School of Medicine

Established in 1807, the University of Maryland School of Medicine is the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. http://www.medschool.umaryland.edu.

About the University of Marlene and Stewart Greenebaum Cancer Center

The University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated center in Baltimore affiliated with the University of Maryland Medical Center and University of Maryland School of Medicine, offers a multidisciplinary approach to treating all types of cancer and has an active cancer research program. It is ranked in the top 50 cancer programs in the nation by U.S. News & World Report. For more information, go to http://www.umgcc.org.

University of Maryland Medical Center

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.